Can Solinco be used to treat neurogenic bladder after chemotherapy and peripheral neuropathy?

Solinco (solifenacin) is a medication used to treat symptoms of an overactive bladder, such as urgency and pollakiuria.

Neurogenic bladder is a disorder of bladder function resulting from damage to the nervous system, which can be caused by a variety of factors, including peripheral neuropathy after chemotherapy. Peripheral neuropathy, the result of peripheral nerve damage, can affect bladder control

Although Solinco works by reducing the activity of an overactive bladder, the safety and efficacy of this drug for neurogenic bladder have not yet been sufficiently established. In the summary of product characteristics, there are no direct indications for the use of Solinco in the treatment of neurogenic bladder.

In addition, patients with difficulty emptying their bladder (e.g. due to neuropathy) should be particularly careful as there is a risk of urinary retention. For this reason, it is recommended to consult a specialist doctor before starting therapy, who will assess the individual risks and benefits of using Solinco.

If you need more personalized advice, you can use teleconsultations here:

https://www.gdziepolek.pl/telekonsultacja/

The availability of Solinco in pharmacies in Polish can be checked at the following address:

https://www.gdziepolek.pl/produkty/103614/solinco-tabletki-powlekane/apteki